Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Nausea × Sugars × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 cyclopia sequence 1 Vomiting 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Myasthenia Gravis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Lower Urinary Tract Symptoms 1 Leiomyoma 1 Insulin Resistance 1 Infertility 1 Hyperandrogenism 1 Hot Flashes 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1

Interventions

dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Dexamethasone 2 Calcium Dobesilate 2 Aprepitant 2 fosaprepitant 1 dolasetron 1 casopitant 1 Sugars 1 Platinum 1 Palonosetron 1 Olanzapine 1 Neoadjuvant Therapy 1 Methadone 1 Immunoenzyme Techniques 1 Haloperidol 1 Granisetron 1 Esomeprazole 1 Cyproheptadine 1 Cyclophosphamide 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Carboplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated

43 enrolled 5 charts

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡